Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Thomas Bengtsson
StatMind
Lund
Sweden
Contact
StatMind
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
922
TOTAL CITATIONS
1
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled Trial
Number of pages: 25
Posted: 08 Feb 2021
Sanjay Ramakrishnan
,
Dan V. Nicolau
,
Beverly Langford
,
Mahdi Mahdi
,
Helen Jeffers
,
Christine Mwasuku
,
Karolina Krassowska
,
Ian Binnian
,
Victoria Glover
,
Stephen Bright
,
Christopher Butler
,
Jennifer L. Cane
,
Andreas Halner
,
Philippa C. Matthews
,
Louise E. Donnelly
,
Jodie L. Simpson
,
Jonathan R. Baker
,
Nabil T. Fadai
,
Stefan Peterson
, Thomas Bengtsson,
Peter J. Barnes
,
Richard EK Russell
and
Mona Bafadhel
University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, Eynsham Medical Group, White Horse Medical Practice, Windrush Medical Practice, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Medicine, Imperial College London - National Heart and Lung Institute (NHLI), University of Newcastle (Australia) - Priority Research Centre for Healthy Lungs, Imperial College London - National Heart and Lung Institute (NHLI), University of Nottingham, StatMind, StatMind, Imperial College London - National Heart and Lung Institute (NHLI), University of Oxford - Nuffield Department of Clinical Medicine and University of Oxford - Respiratory Medicine Unit
Downloads
852
(70,639)
Citation
1
View PDF
Download
Abstract:
2.
Seven Days Treatment With the Angiotensin II Type 2 Receptor Agonist C21 in Hospitalized COVID-19 Patients: A Placebo-Controlled Randomized Phase 2 Trial
Number of pages: 30
Posted: 23 Jul 2021
Göran Tornling
,
Rohit Batta
,
Joanna C. Porter
,
Bryan Williams
, Thomas Bengtsson,
Kartikeya Parmar
,
Reema Kashiva
,
Anders Hallberg
,
Anne Katrine Cohrt
,
Kate Westergaard
,
Carl-Johan Dalsgaard
and
Johan Raud
Karolinska Institutet, Vicore Pharma AB, University College London - Centre for inflammation and Tissue Repair, University College London, StatMind, B.J. Medical College, Asarwa, Noble Hospitals Pvt. Ltd, Hadapsar - Department of Medicine, Uppsala University, Vicore Pharma AB, Vicore Pharma AB, Vicore Pharma AB and Karolinska Institutet
Downloads
70
(875,328)
View PDF
Download
Abstract:
Feedback